Encephalitis: Clinical Trials

3 trials for Encephalitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 withdrawn. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Withdrawn 3

Follow Encephalitis: new trials by email Literature Review of Encephalitis trials Research Report on Encephalitis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immune Response in IXIARO Batch JEV09L37 Recipients Before and After Revaccination
IXIARO - Japanese Encephalitis
Phase 1WithdrawnValneva Austria GmbH2012-06-012013-03-08
Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vaccine
VEE 3526 - Venezuelan Equine Encephalitis
Phase 1WithdrawnDynPort Vaccine Company LLC, A GDIT Company2005-07-012015-09-18
A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease.
Foscarnet sodium, Ganciclovir - Encephalopathy, HIV Infections
Phase 1WithdrawnNational Institute of Allergy and Infectious Diseases (NIAID)2021-10-29

Narrower conditions

AIDS-Related Opportunistic Infections (1)  ·  Brain Diseases (1)  ·  Cytomegalovirus Infections (1)  ·  Encephalitis, Japanese (1)  ·  Encephalomyelitis, Venezuelan Equine (1)  ·  HIV Infections (1)  ·  Multiple Acyl Coenzyme A Dehydrogenase Deficiency (1)  ·  Radiculopathy (1)

Broader conditions

Central Nervous System Diseases (3)  ·  Infections (3)  ·  Nervous System Diseases (3)  ·  Neuroinflammatory Diseases (3)  ·  RNA Virus Infections (3)  ·  Virus Diseases (3)  ·  Arbovirus Infections (2)  ·  Brain Diseases (2)  ·  Central Nervous System Infections (2)  ·  Central Nervous System Viral Diseases (2)  ·  Encephalitis, Arbovirus (2)  ·  Encephalitis, Viral (2)  ·  Infectious Encephalitis (2)  ·  Mosquito-Borne Diseases (2)

Interventions

Foscarnet (1)  ·  Ganciclovir (1)

Sponsors

DynPort Vaccine Company LLC, A GDIT Company (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Valneva Austria GmbH (1)

Countries

United Kingdom (1)  ·  United States (1)

Top investigators

Clifford D (1)  ·  Tselis A (1)  ·  Vera Kadlecek, Mag. (1)